Last reviewed · How we verify
NCT04445909
Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients
trial testing VA-ECMO in Carbon Dioxide in 30 participants. Currently enrolling.
31 January 2025
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 18 November 2019 |
| Primary completion | 31 January 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- VA-ECMO
Conditions studied
- Carbon Dioxide — all drugs for Carbon Dioxide →
Sponsor
Medical University of Vienna
Who can join
Adults 18 to 90, any sex, with Carbon Dioxide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monitoring of end-tidal carbon dioxide tensions is limited, which can result in marked swings towards non-physiological values. Hyper- and hypocapnia, however, can have detrimental effects on organ perfusion in a great number of patients supported with VA-ECMO. Continuous, rapidly applicable monitoring of reliable carbon dioxide measures would therefore be extremely helpful to prevent harmful deviations from the norm. The investigators therefore try to assess the accuracy and the precision of continuously measured non-invasive transcutaneous carbon dioxide partial pressures when compared with tensions determined by blood gas analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04445909
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of VA-ECMO
Trials testing the same drug.
- NCT07053618 — Interventional Left Ventricular Assist System for PCI in CHIP Patients · NA · recruiting
- NCT06373120 — Interventional Ventricular Assist System for PCI in CHIP Patients · NA · active not recruiting
- NCT05577195 — Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO · NA · unknown
- NCT04184635 — Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock · NA · recruiting
- NCT03813134 — Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock · NA · unknown
Other recruiting trials for Carbon Dioxide
Currently open trials in the same condition.
- NCT06547411 — Effects of Different Anesthesia Machine Modalities on Bariatric Surgery Patients: a Prospective Randomized Controlled St · NA · recruiting
- NCT05297266 — Early Discovery of Ischemia After Replantation Surgery of the Extremities · NA · recruiting
- NCT05051397 — CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke · Phase 2 · recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04445909 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04445909.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing